butolame has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Figueroa, A; Lemini, C; Miranda, LD; Mirzaei, E; Prado-Garcia, H; Segovia-Mendoza, M | 1 |
| Estela Avila, M; Figueroa, A; García-Mondragón, MJ; Jiménez-Orozco, A; Lemini, C; Medina, M; Sánchez, C; Vargas-Vázquez, A | 1 |
2 other study(ies) available for butolame and Breast Neoplasms
| Article | Year |
|---|---|
The Interplay of GPER1 with 17β-Aminoestrogens in the Regulation of the Proliferation of Cervical and Breast Cancer Cells: A Pharmacological Approach.
Topics: Amino Alcohols; Breast Neoplasms; Cell Proliferation; Estradiol; Estrenes; Estrogens; Female; Humans; Ligands; Molecular Docking Simulation; Oncogene Proteins; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2022 |
Proliferative Properties of 17β-aminoestrogens in MCF-7 Human Breast Cancer Cells.
Topics: Amino Alcohols; Breast Neoplasms; Cell Proliferation; Estradiol; Estrenes; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogen Replacement Therapy; Female; Humans; MCF-7 Cells; Postmenopause; S Phase; Selective Estrogen Receptor Modulators | 2017 |